APLS stock news
This page provides real-time market news, earnings updates, and company announcements related to Apellis Pharmaceuticals, Inc. (APLS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 17:43 EST
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Finviz2026-02-18 16:04:05
Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Finviz2026-02-19 12:03:41
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Finviz2026-02-24 12:03:58
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates
Finviz2026-02-24 17:03:07
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Finviz2026-03-02 12:03:46
Here is Why JPMorgan is Overweight on Apellis Pharma (APLS)
Finviz2026-03-10 12:03:12
Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
华尔街见闻2026-03-31 11:00:58
Pre-market Highlights for US Stocks: All Three Major Index Futures Rise Over 1%! Nvidia Invests $2 Billion in Marvell Technology
格隆汇2026-03-31 12:50:14
Biogen shares suffered a heavy setback, with intraday losses widening to 7.7%—the lowest level since January this year—after the company announced a $5.6 billion acquisition of Apellis Pharmaceuticals Inc.
老虎证券2026-03-31 13:43:28
Investment firm Baird has announced the downgrade of Apellis Pharmaceuticals Inc. stock rating from "outperform" to "neutral"
老虎证券2026-04-01 03:26:34
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates
Finviz2026-02-24 17:03:07
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Finviz2026-03-02 12:03:46
Here is Why JPMorgan is Overweight on Apellis Pharma (APLS)
Finviz2026-03-10 12:03:12
Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
华尔街见闻2026-03-31 11:00:58
Pre-market Highlights for US Stocks: All Three Major Index Futures Rise Over 1%! Nvidia Invests $2 Billion in Marvell Technology
格隆汇2026-03-31 12:50:14
Biogen shares suffered a heavy setback, with intraday losses widening to 7.7%—the lowest level since January this year—after the company announced a $5.6 billion acquisition of Apellis Pharmaceuticals Inc.
老虎证券2026-03-31 13:43:28
Investment firm Baird has announced the downgrade of Apellis Pharmaceuticals Inc. stock rating from "outperform" to "neutral"
老虎证券2026-04-01 03:26:34
APLS stock chart
APLS stock detailsAPLS stock price change
On the last trading day, APLS stock closed at 40.84 USD, with a price change of 0.12% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more